drugset / Trial / NCT00689598
Spironolactone for Paroxysmal Atrial Fibrillation
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine whether or not spironolactone can prevent or delay the occurrence of atrial fibrillation.
Timeline
- Start
- 2008-03
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spironolactone | Small molecule | 25 mg | Oral |